Crossmark

Next-gen oncology: the role of CAR-T cells against ocular lymphoma and myeloma

Crossref DOI link: https://doi.org/10.1038/s41433-024-03324-6

Published Online: 2024-09-12

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Masalkhi, Mouayad https://orcid.org/0000-0003-0811-358X
Wahhoud, Noura https://orcid.org/0009-0009-9143-5440
Elhassadi, Ezzat
License Information

Text and Data Mining valid from 2024-09-12

Version of Record valid from 2024-09-12
More Information

Article History

Received: 26 July 2024

Revised: 2 August 2024

Accepted: 3 September 2024

First Online: 12 September 2024

Competing interests

: The authors declare no competing interests.